-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Price Target Cut to $7.00/Share From $9.00 by HC Wainwright & Co.

Dow Jones·03/10/2026 12:05:00

Please log in to view news